Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP-110 phase 3 study in adult narcolepsy with excessive sleepiness
NL-OMON43610Phase 3Active, not recruiting
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of solriamfetol in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started May 2015; status: active, not recruiting.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON43610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43610.